From the Literature

  • Acalabrutinib Demonstrates Efficacy and Safety in Relapsed CLL
  • Atezolizumab Shows Durable Response, Tolerability in Urothelial Carcinoma
  • Anti-CD19 CAR T-Cells Show Promise in B-Cell Cancer
  • Lenvatinib Prolongs Progression-Free Survival in Advanced Thyroid Cancer
  • Ruxolitinib More Effective Than Standard Therapy in the Treatment of Polycythemia Vera

A Phase 3 Trial Comparing Axitinib and Sorafenib in Advanced Renal-Cell Cancer

Results 1 - 3 of 3